Supplier profile
Orion Pharma, S. L.
Every public-sector award we hold for this supplier, across Spain, from 7 Jun 2010 to 9 Jun 2026.
Awards won
87
all time
Attributed value
€28.6m
50 shared, unvalued
Buyers
67
public bodies
Active
2010–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Consorci de Salut i d'Atenció Social de Catalunya | 4 | not attributable |
| Consorci Sanitari del Maresme | 3 | not attributable |
| Gerencia de los servicios Sanitarios del Area de Salud de La Palma | 3 | €4k |
| Hospital Universitario Puerta de Hierro de Majadahonda | 3 | not attributable |
| Servicio Murciano de Salud | 3 | not attributable |
| Badalona Serveis Assistencials, SA | 2 | not attributable |
| Consorci Sanitari de l'Anoia | 2 | not attributable |
| Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | 2 | not attributable |
| Dirección del Instituto Nacional de Gestión Sanitaria (INGESA) | 2 | €2.1m |
| Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau | 2 | not attributable |
What they win
Awards
Showing 1–25 of 87 awards we hold
- Spain – Various medicinal products – Acuerdo Marco del Suministro del MEDICAMENTO RANIBIZUMAB ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 9 Jun 2026
- Spain – Immunosuppressive agents – Suministro respetuoso con el medio ambiente, de medicamentos bilógicos con biosimilares destinado a los centros del ámbito de la sanidad pública valenciana ↗Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidadshared awardawarded 5 Jun 2026
- Spain – Immunosuppressive agents – Suministro respetuoso con el medio ambiente, de medicamentos bilógicos con biosimilares destinado a los centros del ámbito de la sanidad pública valenciana ↗Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidadshared awardawarded 5 Jun 2026
- Spain – Pharmaceutical products – Acuerdo Marco de Medicamentos ↗Gerencia del Hospital Intermutual de Levanteshared awardawarded 9 Apr 2026
- Spain – Ophthalmologicals – Acuerdo Marco para el suministro, respetuoso con el medio ambiente, de medicamentos biológicos con biosimilares, para varias comunidades autónomas, centros del Instituto Nacional de Gestión Sanitaria (INGESA) en Ceuta y Melilla y organismos de la Administración del Estado ↗Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)shared awardawarded 25 Nov 2025
- Acuerdo Marco para el suministro, respetuoso con el medio ambiente, de medicamentos biológicos con biosimilares, para varias comunidades autónomas, centros del Instituto Nacional de Gestión Sanitaria (INGESA) en Ceuta y Melilla y organismos de la Administración del Estado ↗Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)€2.1mawarded 25 Nov 2025
- Suministro BAM 2024/011062 lote 06 RANIBIZUMAB 0,5 mg (utilizable) intravítreo ↗Gerencia del Area de Atención Integrada de Manzanares€13kawarded 4 Sept 2025
- Contrato basado en Lote 6 AM 2024/011062-Medicamentos biológicos ↗Gerencia de Atención Integrada de Talavera de la Reina€9kawarded 2 Sept 2025
- Lote 6 Adquisición Ranibizumab 0.5mg (utilizable) Intravitreo. AM 2024/011062 ↗Gerencia de Atención Integrada de Ciudad Real€1kawarded 12 Aug 2025
- Medicamentos biológicos 60 jeringas lote 6 Ranibizumab 0.5 mg utilizable intra vítreo CD AM2024/011062 ↗Gerencia de Atención Integrada de Albacete€5kawarded 8 Aug 2025
- Medicamentos Biológicos L6 Ranibizumab intravitreo ↗Gerencia de Atención Integrada de Cuenca€5kawarded 1 Aug 2025
- CBAM 2024/011062, Medicamentos biológicos, Lote 6 , Ranibizumab 0,5 mg intravítreo. ↗Gerencia de Atención Integrada de Puertollano€5kawarded 31 Jul 2025
- Adquisición de RANIBIZUMAB 0,5 MG (UTILIZABLE) INTRAVITREO para la G.A.I. de Guadalajara. Contrato basado en A.M. 2024/011062 (Lote 6), para la selección de proveedores de medicamentos biológicos para los centros dependientes del Sescam. ↗Gerencia del Area de Atención Integrada de Guadalajara€36kawarded 15 Jul 2025
- Spain – Pharmaceutical products – Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca. ↗Gerencia Sector Sanitario de Huescashared awardawarded 10 Jul 2025
- Spain – Pharmaceutical products – Suministro de Lacosamida (DOE), Daptomicina (DOE), Abacavir (DOE), Ambrisentan (DOE), Eribulina (DOE), Darunavir (DOE), Pomalidomida (DOE) y Dexmedetomidina (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Centralshared awardawarded 3 Jul 2025
- Spain – Pharmaceutical products – Acuerdo Marco para la Selección de Proveedores de Medicamentos Biológicos para los Centros Dependientes del SESCAM ↗Secretaria General del Servicio de Salud de Castilla-La Manchashared awardawarded 16 May 2025
- Spain – Pharmaceutical products – Suministro de Pregabalina (DOE), Oxibato de sodio (DOE), Nevirapina (DOE), Levosimendan (DOE) y Natalizumab (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Centralshared awardawarded 5 Apr 2025
- Spain – Various medicinal products – medicamentos_antibioticos, antifúngicos y otros ↗Servicio de Salud - Servicios Centralesshared awardawarded 27 Mar 2025
- Spain – Pharmaceutical products – EXP. 2024-104 Suministro de medicamentos diversos II con destino el Hospital Clínic de Barcelona (HCB). ↗CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)shared awardawarded 7 Mar 2025
- Spain – Medicinal products for dermatology and the musculo-skeletal system – SUMINISTRO DE MEDICAMENTOS CON PRINCIPIOS ACTIVOS CISATRACURIO 2 MG/ML, DEXKETOPROFENO PARENTERAL, FENTANILO PARENTERAL, FLUMAZENIL, HIERRO SACAROSA, LACOSAMIDA PARENTERAL, LEVOSIMENDAN, NOREPINEFRINA, PALIPERIDONA INTRAMUSCULAR MENSUAL, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIO, SUGAMMADEX, TOXINA BOTULINICA TIPO A 50 UNIDADES, TOXINA BOTULINICA TIPO A 100 UNIDADES Y TOX ↗SERVICIO MURCIANO DE SALUDshared awardawarded 5 Sept 2024
- Spain-Barcelona: Various medicinal products ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 29 Dec 2023
- Spain-Barcelona: Various medicinal products ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 15 Dec 2023
- Spain-Majadahonda: Pharmaceutical products ↗Hospital Universitario Puerta de Hierro de Majadahondashared awardawarded 22 Sept 2023
- Spain-Tortosa: Pharmaceutical products ↗GESTIO SANITARIA I ASSISTENCIAL DE TORTOSA, S.A.M.shared awardawarded 12 Sept 2023
- Spain-Mataró: Various medicinal products ↗Consorci Sanitari del Maresmeshared awardawarded 11 Jul 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Orion Pharma A/S110 awards
- Orion Pharma AB65 awards
- Orion Pharma GmbH44 awards
- ORION PHARMA S.R.L.31 awards
- Orion Pharma (UK) Ltd26 awards
- Orion Pharma15 awards
- Orion Pharma BV5 awards
- ORION Pharma GmbH (BG InfectoPharm Chiesi Orion Pharma GbR)2 awards
- ORION Pharma GmbH [BG TEVA / ORION Pharma GbR (ratiopharm, TEVA, ORION Pharma)]2 awards
- ORION PHARMA ( Rang 2)2 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.